Literature DB >> 22520131

Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.

C Lloyd-Johnsen1, F Justice, S Donath, J E Bines.   

Abstract

UNLABELLED: Evaluation of the safety of rotavirus vaccines, particularly with respect to the risk of intussusception, is recommended for countries planning to introduce rotavirus vaccines into the National Immunisation Program. However, as prospective studies are costly, require time to conduct and may be difficult to perform in some settings, retrospective hospital based surveillance at sentinel sites has been suggested as an option for surveillance for intussusception following introduction of rotavirus vaccines.
OBJECTIVE: To assess the value of retrospective hospital based surveillance to describe clinical and epidemiological features of intussusception in children aged <24 months and to investigate any temporal association between receipt of a rotavirus vaccine and intussusception.
METHODS: A retrospective chart review of all patients diagnosed with intussusception at Royal Children's Hospital, Melbourne, Australia over an 8-year period including before and after rotavirus vaccine introduction into the National Immunisation Program, was conducted using patients identified by a medical record database (ICD-10-CM 56.1). Patient profile, clinical presentation, treatment and outcome were analysed along with records of immunisation status obtained using the Australian Childhood Immunisation Register.
RESULTS: A 9% misclassification rate of discharge diagnosis of intussusception was identified on critical chart review. The incidence rate of intussusception at the Royal Children's Hospital over the study period was 1.91 per 10,000 infants <24 months (95% CI 1.65-2.20). Intestinal resection was required in 6.5% of infants (95% CI 3.6%, 11.0%). Intussusception occurred within 30 days after vaccination in 2 of 27 patients who had received at least 1 dose of a rotavirus vaccine.
CONCLUSIONS: Valuable data on the incidence, clinical presentation and treatment outcomes of intussusception can be obtained from data retrieved from hospital medical records in a sentinel paediatric hospital using standardised methodology. However, there are methodological limitations and the quality of the data is highly dependent on the accuracy and completeness of the patient information recorded, the system of coding and record retrieval.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520131     DOI: 10.1016/j.vaccine.2011.11.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries.

Authors:  Prashant Kumar; Ravi S Shukla; Ashaben Patel; Swathi R Pullagurla; Christopher Bird; Oluwadara Ogun; Ozan S Kumru; Ahd Hamidi; Femke Hoeksema; Christopher Yallop; Julie E Bines; Sangeeta B Joshi; David B Volkin
Journal:  Hum Vaccin Immunother       Date:  2021-04-16       Impact factor: 3.452

2.  [A rare case of suppurative mesenteric adenitis associated with intussusception in a child: a clinical case].

Authors:  Didier Tshibangu Mujinga; François Tshilombo Katombe
Journal:  Pan Afr Med J       Date:  2016-03-31

3.  Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.

Authors:  Julie E Bines; Jarir At Thobari; Cahya Dewi Satria; Amanda Handley; Emma Watts; Daniel Cowley; Hera Nirwati; James Ackland; Jane Standish; Frances Justice; Gabrielle Byars; Katherine J Lee; Graeme L Barnes; Novilia S Bachtiar; Ajeng Viska Icanervilia; Karen Boniface; Nada Bogdanovic-Sakran; Daniel Pavlic; Ruth F Bishop; Carl D Kirkwood; Jim P Buttery; Yati Soenarto
Journal:  N Engl J Med       Date:  2018-02-22       Impact factor: 91.245

Review 4.  Countering vaccine hesitancy through immunization information systems, a narrative review.

Authors:  Vincenza Gianfredi; Massimo Moretti; Pier Luigi Lopalco
Journal:  Hum Vaccin Immunother       Date:  2019-06-21       Impact factor: 3.452

5.  Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery.

Authors:  Prashant Kumar; Swathi R Pullagurla; Ashaben Patel; Ravi S Shukla; Christopher Bird; Ozan S Kumru; Ahd Hamidi; Femke Hoeksema; Christopher Yallop; Julie E Bines; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2020-10-07       Impact factor: 3.534

Review 6.  Childhood intussusception: a literature review.

Authors:  James Jiang; Baoming Jiang; Umesh Parashar; Trang Nguyen; Julie Bines; Manish M Patel
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

7.  Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study.

Authors:  Francesco Trotta; Roberto Da Cas; Antonino Bella; Carmela Santuccio; Stefania Salmaso
Journal:  Ital J Pediatr       Date:  2016-09-27       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.